Last reviewed · How we verify
mild to moderate dementia of the Alzheimer's type
Approved treatments
- Zunveyl · Alpha Cognition
Zunveyl works by enhancing communication between brain cells, specifically by stimulating cholinergic receptors.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- mild to moderate dementia of the Alzheimer's type patent landscape — cliff calendar, originator estates, attackable patents
- mild to moderate dementia of the Alzheimer's type treatment landscape brief
- mild to moderate dementia of the Alzheimer's type treatment updates RSS
Frequently asked questions about mild to moderate dementia of the Alzheimer's type
What drugs treat mild to moderate dementia of the Alzheimer's type?
Tracked treatments include Zunveyl.
What is the treatment for mild to moderate dementia of the Alzheimer's type?
Standard treatment for mild to moderate dementia of the Alzheimer's type includes Zunveyl. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: mild to moderate dementia of the Alzheimer's type patent cliff · mild to moderate dementia of the Alzheimer's type CI report
- Treatment: Zunveyl · Alpha Cognition
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing